This study shows that the fasting glucagon concentrations are lowered in patients with VLCAD, i.e., the genetically-induced impairment of fatty acid β-oxidation appears to be associated with hypoglucagonemia also in humans. Here, GCG is linked to very long chain acyl-CoA dehydrogenase deficiency.